Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
P16444
UPID:
DPEP1_HUMAN
Alternative names:
Beta-lactamase; Dehydropeptidase-I; Microsomal dipeptidase; Renal dipeptidase
Alternative UPACC:
P16444; D3DX80; Q96AK2
Background:
Dipeptidase 1, also known as Dehydropeptidase-I, Beta-lactamase, Microsomal dipeptidase, and Renal dipeptidase, is a versatile enzyme with a broad substrate range. It plays a crucial role in metabolizing dipeptides, including the conversion of leukotriene D4 to leukotriene E4, and in the degradation of glutathione. Additionally, it exhibits beta-lactamase activity, enabling it to hydrolyze beta-lactam antibiotics like imipenem. Beyond its enzymatic functions, Dipeptidase 1 serves as an adhesion receptor, facilitating neutrophil recruitment into inflamed lungs and liver.
Therapeutic significance:
Understanding the role of Dipeptidase 1 could open doors to potential therapeutic strategies. Its involvement in neutrophil recruitment and antibiotic degradation highlights its significance in immune response and antibiotic resistance, respectively, offering avenues for targeted drug development.